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sign “please, knock before you enter”. 
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$%:#9*"%;)%39*(*1:3';)%;%90KThe term “homosexual” originated in a sexological discourse of 











Q^HfRwith its original meaning “men who have sex with men but do not identify as gay”>*;);)%7<973:%






STI field and was probably aided by the fact that “gay “ was seen as inaccurate in many nonO%:;%91
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when “there has bee1:%1:%;);>%/9%$@.13>will not work” QfR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9%*1(%1%9/13t “an easy to reach” populationand are frequently referred to as “hidden 
population”. 
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consensus that any HIV+ person with CD4 counts less than 350 cells/μl should be treated, it remains 
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*:31verage 13 times higher than that in the country’s general population Q_eRK1:07/*1(H>)*#)*:
01@;*0%:13;1;*31//@9%79%:%1;;*=%H:*;*:039%/*.%/@#31$<#;%$*1;)%#7*;/:H<937%1























































































































Sharing semen (“cum play”) can include ejaculation over the anus, rubbing semen over the anus or using 
:%0%1:/<"9*#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
;91:0*::*31Qe`RK'390of semen exchange called “felching’’ involves oral ingestion of semen from a 









3':%?</79#;*#%:3': “nudging” (touching or rubbing of another man’s anus with the penis 
without a condom); “dipping” (partly inserting or briefly inserting the penis into the anus without a 









,#)2what I am, no matter how I am.“
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Members of the “core group”, who have multiple sex partners and change them frequently, 9%039%


































#311%#;*31:(i.e. “high density networks”)H*1>)*#)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;131Ogay homosexually active men might represent a group, “substantially less at 
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1%3<:#<9%3':30%Hthe numbers in the surveillance system represent only the “tip of the 
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referred to as “partner notification”).;*:9%:731:*"*/*;@3'7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Intentional UAI, in which STI transmission is a possibility, has been referred to as “barebacking” and 
#99*%:#3113;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subculture with “bug chasing” (intentional UAI with a HIV serodiscorcondant partner) and corresponding 











risky “cum play” with their partner on the same occasion, due to semen potentially having great 
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likely to be used during ‘‘rougher’’ sex QfbRK/:33;)%9$9<(:/*.%#:;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Qdestinations with “party atmosphere” like (@9%:39;H)3;:73;=:K3;)%9H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9%%0%9(*1(HPrestage’s criticism that MSM are largely (in 























9%:</;*1(*19%/;*=%/@/3>793739;*313'H>)3*$%1;*'@as “homosexual” (39.7%) and a higher 





































































































































































*1cooperation with “Gay and Lesbian Health 
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Self-reported sexually transmitted infections and
their correlates among men who have sex with
men in Norway: an Internet-based cross-sectional
survey
Irena Jakopanec1, Barbara Schimmer2, Andrej M Grjibovski1,3,4, Elise Klouman1,3, Preben Aavitsland1*
Abstract
Background: The incidences of reportable sexually transmitted infections (STI) among men who have sex with men
(MSM) have increased since the late 1990 s in Norway. The objectives of our study were to assess factors, associated
with recent selected STI among MSM, living in Norway in order to guide prevention measures.
Methods: We conducted a cross-sectional Internet-based survey during 1-19 October 2007 among members of a
MSM-oriented Norwegian website using an anonymous questionnaire on demographics, sexual behaviour, drug
and alcohol use, and STI. The studied outcomes were gonorrhoea, syphilis, HIV or Chlamydia infection in the
previous 12 months. Associations between self-reported selected STI and their correlates were analysed by
multivariable Poisson regression. P value for trend (p-trend), adjusted prevalence ratios (PR) with 95% confidence
intervals [] were calculated.
Results: Among 2430 eligible 16-74 years old respondents, 184 (8%) reported having had one of the following: syphilis
(n = 17), gonorrhoea (n = 35), HIV (n = 42) or Chlamydia (n = 126) diagnosed in the past 12 months. Reporting
Chlamydia was associated with non-western background (PR 2.8 [1.4-5.7]), number of lifetime male partners (p-trend <
0.001), unsafe sex under the influence of alcohol (PR 1.8 [1.1-2.9]) and with younger age (p-trend = 0.002). Reporting
gonorrhoea was associated with unrevealed background (PR 5.9 [1.3-26.3]), having more than 50 lifetime male partners
(PR 4.5 [1.3-15.6]) and more than 5 partners in the past 6 months (PR 3.1 [1.1-8.8]), while mid-range income was
protective (PR 0.1 [0.0-0.6]). Reporting HIV was associated with residing in Oslo or Akershus county (PR 2.3 [1.2-4.6]), non-
western background (PR 5.4 [1.9-15.3]), unrevealed income (PR 10.4 [1.5-71.4]), number of lifetime male partners
(p-trend < 0.001) and being under the influence of selected drugs during sex in the past 12 months (PR 5.2 [2.7-11.4]).
In addition, the frequency of feeling drunk was reversibly associated with HIV.
Conclusions: Our study demonstrates different associations of demographic and behavioural factors with different
STI outcomes in the study population. Number of lifetime male partners was the most important potential
predictor for Chlamydia and HIV. The STI prevention efforts among MSM should focus on Oslo and Akershus,
promote safe sex practices and tackle sex-related drug and alcohol use.
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Background
Since the mid-1990 s, sexually transmitted infections
(STI) among men who have sex with men (MSM) have
been reported to be on the rise in many European coun-
tries [1] and worldwide [2,3]. Increasing numbers of
HIV infections, gonorrhoea and syphilis among men,
infected by other men, have been also observed in the
Norwegian surveillance system for communicable dis-
eases [4-6]. Chlamydia is the most common reportable
STI in Norway [7] and although MSM-specific data are
not available, the rate among Norwegian men in 2007
was as high as 368/100 000 person-years. The STI trans-
mission mainly occurs in the capital Oslo and neigh-
bouring Akershus county, where the MSM population is
concentrated [5,8]. The surveillance system collects only
limited information on STI patients and specific knowl-
edge about sexual risk behaviour among MSM living in
Norway is very limited.
The MSM population is frequently referred to as “hid-
den” [9,10] due to its unknown size and difficulties to
reach. Internet websites have been shown to be conveni-
ent cost-effective tools for recruitment of MSM [11]. In
2007, 78% of all households in Norway had Internet
access and 88% of men between 16-74 years old have
used it recently [12]. Sampling on the Internet may be
also more convenient to attract those men, who may be
less likely to self-identify as MSM [9].
The objective of this study was to assess the associa-
tions between selected factors and self-reported STI in
the past 12 months among MSM, living in Norway.
Methods
Participants and Recruitment
An Internet cross-sectional survey was initiated by the
Norwegian Institute of Public Health, in cooperation
with “Gay and Lesbian Health Norway”. Participation
was offered to logged-in members of the Norwegian
MSM-oriented website from 1 October 2007 to 19
October 2007. This is the leading website for the MSM-
net-community in the Norwegian language with more
than 31 000 member profiles. The site has about 50 000
visits each week and provides news items, a chat-com-
munity, a discussion forum, an events calendar, links
and other information. When clicking on the study ban-
ner, the participants were guided to an introduction,
where the aims and structure of the study were
explained. Anonymity of the participants was assured
and contact persons for the study from collaborating
institutions were provided. The participation was volun-
tary. Respondents, who answered that they were
women, younger than 16 years, had never had sex with
a man or were living abroad, were excluded from the
analysis.
Selected outcomes
We focused our analysis on MSM, who reported being
diagnosed with any of the following STI in the previous
12 months: gonorrhoea, syphilis, HIV or Chlamydia
infection ("selected STI”). To check if selected exposures
are differently associated with a specific STI, we per-
formed multivariable analyses for Chlamydia, gonor-
rhoea and HIV infection as separate outcomes (Table 1),
but due to the low number of cases, this was not possi-
ble for syphilis.
Pilot study
An offline and online testing of the questionnaire was
conducted by 15 MSM, who provided a detailed feed-
back on the content, functionality and the questionnaire
layout.
Data collection
Data were collected using the online survey tool Quest-
back and harvested in Excel format.
Measures and data presentation
Demographic characteristics and sexual behaviour were
initially classified as presented in Tables 2 and 3; how-
ever some categories within variables were merged in
multivariable analysis as presented in the Table 4. The
variables health region and residing in Oslo/Akershus
county were created from the “county of residence” vari-
able. The variable “drugs before sex” was created based
on reports of using any of the following drugs before
sex: marihuana, prescription drugs, ecstasy, LSD, GHB,
cocaine, heroine, amphetamines or methamphetamines.
Statistical analyses
We used Stata 9.0 for the analyses. Associations between
reported recent selected STI and categorical indepen-
dent variables with and without adjustment for potential
confounders were studied by Poisson regression with
robust variance estimates [13]. Crude and adjusted pre-
valence ratios (PR) with 95% confidence intervals (CI)
were calculated. Three separate multivariable models
were generated (Table 1) and they included variables,
associated with the outcome at p < 0.15 [14] in crude
analysis as well as variables, previously shown as predic-
tors of STI. Where the unknown or missing were statis-
tically different in the crude analysis from the rest of the
categories within a variable, they were entered in multi-
variable analysis as a separate category, as presented in
the Table 4, otherwise they were excluded. The variable
“ever had a date in reality with a partner from the Inter-
net” was not included in the multivariable analysis with
gonorrhoea as an outcome due to a zero variance of this
potential predictor. Variables health region and residing
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in Oslo/Akershus were created from the same original
variable and, due to our study question, only the latter
was selected for multivariable analysis.
In each multivariable model, we excluded those, who did
not report an outcome of interest, but were infected with
another selected STI - as presented in the Table 1. In addi-
tion, we also excluded those, reporting Chlamydia and
selected STI in the past 12 months, from the model,
where Chlamydia was a sole outcome. Those with another
STI were included in the outcomes of the other two corre-
sponding models to represent more at risk populations.
Participation in the study was of no direct benefit to the
respondents. The study was approved by the Regional
Committee for Medical and Health Research Ethics, South-
ern Norway, and by the Norwegian Data Inspectorate.
Results
Out of 2598 respondents, 2430 were included in the study
after application of our exclusion criteria. The median age
of respondents was 31 years, ranging from 16 to 74 years.
The respondents were from all regions of Norway,
although half of them lived in Oslo or neighbouring Aker-
shus county (Table 2). Most respondents reported being
ethnic Norwegians (93%) and having university education
(58%). Most men stated their sexual orientation as homo-
sexual (86%), 68% reported more than 10 male sexual
partners in their life and 65% reported having had inter-
course with an anonymous or casual partner in the last 6
months, of which more than a third reported having
unprotected anal intercourse (UAI), (Table 3). We identi-
fied 184 (8%) MSM, infected with a selected STI in the
past 12 months: 17 (0.7%) reported being diagnosed with
syphilis, 35 (1.4%) with gonorrhoea, 42 (1.7%) with HIV
and 126 (5.2%) with Chlamydia. In addition, 26 (1.1%)
respondents reported being diagnosed with HIV prior to
the past twelve months.
Having unsafe sex in the past 12 months under the
influence of alcohol was reported by 26.4%. Those who
reported feeling drunk four times and more in an aver-
age month, represented 38.0% and those who used
selected drugs (marihuana, prescription drugs, ecstasy,
LSD, GHB, cocaine, heroine, amphetamines or metham-
phetamines) in connection to sex represented 9.9% of
the participants (Table 3).
Crude analyses indicated no associations between a
selected STI and age, with the exception of those above
45 years, who were less likely to report Chlamydia
(Table 2). Compared to those in health region East
(which includes Oslo), those living in health region
West in Norway had a lower prevalence ratio for HIV
infection and those in the North for Chlamydia. In
crude analysis, residing in Oslo or Akershus county was
associated with all selected STI. Those with non-western
background were more likely to be recently diagnosed
with Chlamydia, HIV and syphilis; and those, who did
not want to reveal their ethnic background, with gonor-
rhoea. Education did not seem to be associated with any
selected STI in crude analysis, while yearly income,
higher than 300 000 Norwegian crowns, as well as unre-
vealed income, seemed to increase the prevalence ratio
for HIV. Conversely, an income of 300-500 thousand
Norwegian crowns per year seemed to be protective for
gonorrhoea (Table 2).
Among possible sexual exposures, having more than 10
male partners in life was associated with Chlamydia in
crude analysis, but it did not seem to be important for
other selected STI (Table 3). Number of partners in the
past six months was, on the other hand, more important
for Chlamydia, gonorrhoea and syphilis, but not for the
HIV infected. Selected STI were not associated with sex-
ual orientation, choosing partner on the Internet and
steady relationship with either a man or a woman, while
many other risk behaviours were associated with all or at
least two of the selected STI (Table 3).
In the multivariable model, a decreasing linear trend
between Chlamydia and age was observed (p for trend =
0.002), (Table 4). Compared to those without selected
STI, HIV infection was more prevalent among residents
of Oslo or Akershus county, while the results on resi-
dence were inconclusive for gonorrhoea (p = 0.082) and
Chlamydia (p = 0.068). Immigrants with non-western
background were more likely to report HIV and Chla-
mydia infection. While unrevealed income was asso-
ciated with HIV, income did not seem to be relevant for
Chlamydia and was, in the category of 300-500 thousand
Norwegian crowns per year, protective for gonorrhoea.
A positive linear trend between the number of male sex-
ual partners in life and the prevalence of Chlamydia and
Table 1 Overview of the multivariable models, their outcomes and comparison groups in the Internet-based
cross-sectional MSM study
Model Outcome* Comparison group
1. Chlamydia, NO selected STI respondents not reporting any selected STI
2. gonorrhoea or gonorrhoea AND any selected STI respondents not reporting any selected STI
3. HIV infection or HIV infection AND any selected STI** respondents not reporting any selected STI
* all outcomes diagnosed in the past 12 months
**selected STI - syphilis, gonorrhoea, HIV or Chlamydia in the past 12 months
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HIV was observed (p for trend < 0.001), while only the
category above 50 lifetime partners was associated with
gonorrhoea. Number of male sexual partners in the past
six months was not important correlate for Chlamydia
and HIV, but was, above counts of 5, important for
gonorrhoea. The practice of group sex could be a poten-
tial risk factor for Chlamydia (p = 0.069). Receiving
money or paying for sex was not important for any of
the outcomes. The frequency of feeling drunk in an
average month was inversely associated with HIV (p for
trend < 0.001), while reporting unsafe sex under the
influence of alcohol in the past 12 months was corre-
lated to Chlamydia. Being under the influence of
selected drugs during sex in the past 12 months was
associated with HIV infection. Results for having a date
with a partner whom they met on the Internet, and UAI
with a casual or anonymous partner in the last 6 months,
were inconclusive.
Discussion
This is the first Internet study on sexual risk behaviour
among MSM in Norway. Our predominantly well-edu-
cated study population frequently used the Internet for
dating, reported prevalent partner exchange including
recent casual or anonymous partners, and alcohol use.
MSM, being diagnosed with Chlamydia, HIV, gonor-
rhoea or syphilis in the past year represented 8% of our
respondents.
Our results suggest that MSM, who reported any
selected STI in the past year, represent different demo-
graphic groups and groups with different risk behaviours.
Younger age, non-western background, number of lifetime
male sexual partners and unsafe sex under the influence of
alcohol in the past 12 months were factors associated with
Chlamydia. Similarly, non-western background was also
associated with HIV infection, as well as residence in Oslo
or Akershus county, unrevealed income, more than 50
lifetime male sexual partners and being under the influ-
ence of selected drugs during sex in the past 12 months.
HIV infection was decreasingly associated with the fre-
quency of feeling drunk in a given month. Gonorrhoea
was associated with unrevealed ethnic background, more
than 50 lifetime male sexual partners and having more
than 5 male sexual partners in the past 6 months. Report-
ing a mid-range income category seemed to be protective.
Collecting data with no human interviewers and without
any personally identifying information might have been
grounds for more revealing answers on behaviour. Our
study has received considerable public attention and was
well-known among MSM. Thus, we were able to collect
data from relatively large numbers of respondents from all
health regions in Norway. High Internet coverage and
almost universal computer literacy in Norway made our
study widely accessible. Since our questionnaire took
about 45 minutes to complete, we assume double entries
were rare.
Representativeness and generalization of the results to
the entire MSM population in Norway might not be fea-
sible, as Internet sampling is subject to selection bias,
misrepresentation as a member of the sampled popula-
tion, repeated participation, missing data, inability to
gather biological specimens etc. [9]. Those with an STI
in the past year might have been more likely to be
aware of the past risk behaviour (recall bias) - thus over-
estimating the effect size - and to respond as we posted
the banner inviting respondents to “help prevent HIV
infection” (selection bias). Using self-reporting to esti-
mate STI prevalence could introduce measurement
error. The prevalences of self-reported STI in the past
year are likely to be an underestimation in our study, as
some MSM might not be aware of their (sometimes
asymptomatic) current infection or refuse to be tested
[15], which could decrease the associations, found in
our study. Similarly, respondents with an STI, which
was not selected as an outcome, could also decrease
these associations. To estimate the frequency of alcohol
consumption, we used a rather subjective “feeling of
being drunk”. We did not specifically ask whether some
drugs were injected, however such HIV transmission is
rare in Norway due to effective harm reduction pro-
grammes: in total, 10 men were reported being infected
with HIV due to injecting drugs in Norwegian surveil-
lance system for communicable diseases in 2007 and 7
in 2006 [4]. Since no adjustment for multiple compari-
sons was made, some of the significant associations
might appear due to chance. Despite the large number
of participants, we were not able to show statistically
significant effects for rare exposures (such as not having
a date with Internet partner and paying or receiving
money for sex), when the effect size is small. Gonor-
rhoea as an outcome was rare, which limited our power
to detect factors associated with infection. Nonetheless,
we believe the study provides an important insight into
current MSM behaviour in Norway.
Comparing the findings of our study with other stu-
dies is of limited value, as there are notable differences
in recruitment sites, inclusion criteria, methodology
(including definitions) and STI epidemiology among
MSM.
An Internet study from USA, focusing on a six-month
period in 2001, reported 0.3% being newly diagnosed
with syphilis, 1.8% with gonorrhoea and 1.1% with Chla-
mydia; while total HIV prevalence of the participants,
including non-recent infections, was 7.2% [16], similar
to a Danish study from 2006 with 8% [17].
More than a half (57.6%) of our respondents reported
finishing high school or university, which was high com-
pared to corresponding Norwegian male population
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(24.5% in January 2008) [12], but similar findings (55%)
were reported from Danish study recruiting MSM at
different venues and online [17]. Immigrants with non-
western background seemed underrepresented in our
sample (1.7% compared to 6.3% males in Norwegian popu-
lation [18]); perhaps due to language, cultural barriers or
lower proportion of self-identified MSM among them.
A case-control study of MSM from Chicago and Los
Angeles found recent HIV seroconversion to be asso-
ciated with low income, UAI with HIV positive partners,
and using Viagra and poppers [19]. In a longitudinal
American study, HIV acquisition was found to be
related to ethnicity (Black race), use of alcohol or drugs
before sex, receptive UAI, insertive UAI with HIV posi-
tive partners, use of alcohol or drugs before sex, report-
ing 4 or more male partners in the last 6 months,
amphetamines and heavy alcohol use [20].
In a prospective study in Australia, urethral gonor-
rhoea and Chlamydia in MSM were associated with
these common risk factors: younger age, contact with
gonorrhoea or Chlamydia infected sexual partner and a
higher number of casual partners in the past 6 months.
In addition, gonorrhoea was associated with UAI with
HIV positive casual partners, and urethral Chlamydia
with more frequent insertive oral sex with ejaculation
with casual partners. When no receptive UAI was
reported, anal infections with Chlamydia and gonor-
rhoea were associated with a variety of non-intercourse-
receptive anal practices with casual partners [21].
MSM were previously identified as a population with
high prevalence of alcohol use [22]. A review article by
Woolf and Maisto concluded heavy episodic drinking
among MSM is related to HIV infection, while history
or frequency of consumption might not be [22].
Our results suggest Norwegian MSM share some
similarities in risk behaviour with MSM around the
world, perhaps due to sharing popular culture and
ideas on the Internet and an increase in international
travel [3].
Chlamydia, syphilis and HIV infection may be present
for a long time before being noticed or diagnosed, con-
tributing to the fact that relevant exposures, leading to
the infection, might have happened a long time ago and
behaviour might have changed during this time or, par-
ticularly, after the diagnosis and counselling. We can see
that some potential risk factors, limited to the past 6 or
12 months before the study, were not important for
these infections. Number of lifetime male sexual part-
ners seemed to be more important for HIV and Chla-
mydia than number of male sexual partners in the past
6 months. In addition, pharyngeal infections result from
oral sex practices, potentially decreasing the importance
of UAI in transmission of Chlamydia [23], gonorrhoea
and syphilis.
The inverse association of Chlamydia and age was
expected due to diminishing testing activity and preva-
lence after age 40 [7]. Chlamydia is geographically-wide-
spread infection in Norway [24] and clustering of MSM
cases in Oslo or Akershus, as previously described for
gonorrhoea and syphilis [5,6] and as suggested also for
HIV infection, might be less emphasized. Nonetheless,
most MSM in our study do come from Oslo or Aker-
shus and engaging in sex with multiple and casual part-
ners is likely adjacent to the urban lifestyle.
Although reported by only 1.7% of MSM in our study,
non-western background was consistently identified as a
risk factor for Chlamydia and HIV. Immigrants from
areas with a generalised HIV/STI epidemic could be
more likely to know their status as they are offered HIV
testing upon arrival to Norway; but these were not likely
to answer our questionnaire as it was in Norwegian.
Specific reasons for vulnerability of immigrant MSM for
STI in Norway could be a subject of further research.
Alcohol might influence the STI transmission by beha-
viour, sexual arousal, adverse effects on the immune system
or perhaps a third, confounding variable (e.g., “sensation-
seeking”) [25]. MSM may drink to achieve a “cognitive
escape”, for example to avoid “being worried about HIV/
AIDS” [22,26]. Although not significant, prevalence ratio
estimates were highest among “moderate drinkers” (groups
feeling drunk once or up to three times in an average
month) among gonorrhoea and Chlamydia cases. This
might imply drinking in social situations and venues (e.g.,
bars), connected to sensation- and partner-seeking [22].
Our reverse association between the increasing frequency
of feeling under the influence of alcohol and HIV infection
is puzzling; however drugs seem to be a more important
correlate than alcohol in this group. The importance of
alcohol in STI transmission is on the other hand empha-
sized by “unsafe sex under the influence of alcohol in the
past 12 months” associated with higher prevalence ratio for
Chlamydia. Thus, alcohol use in sexual risk behaviour
remains “a controversial topic with mixed findings” [27].
Being under the influence of selected drugs during sex
was associated with reported HIV infection in the last year,
but not with Chlamydia or gonorrhoea. Drugs may be used
before or during sex to enhance sexual pleasure, but their
use may have complex and harmful physiological or cogni-
tive side-effects, enhancing the likelihood of frequent part-
ner change and unprotected anal sex with HIV positive
partners or partners of unknown serostatus [19]. Further
research is needed on the importance of specific drugs in
HIV transmission among MSM in Norway.
Conclusions
This first Internet study on sexual risk behaviour of
MSM in Norway has reached a large and active online
MSM community, thus the possibility of Internet based
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health interventions could be further explored. Our
study demonstrates different associations of demo-
graphic and behavioural factors with different STI out-
comes in the study population. The number of male
sexual partners and ethnic background seem to be the
most important predictors for Chlamydia, gonorrhoea
and HIV. Additional research is needed to analyse the
association of STI with specific drug and alcohol use.
To evaluate time trends and the effectiveness of preven-
tive measures, behavioural studies among MSM in Nor-
way should be repeated regularly.
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Abstract
Background: Gonorrhoea, a bacterial infection caused by Neisseria gonorrhoeae, has been
increasing in several European countries, particularly among men who have sex with men (MSM)
and teenagers. We describe the epidemiology of gonorrhoea in Norway in the recent 15 years in
order to guide recommendations on the diagnosis, treatment and prevention of gonorrhoea. An
evaluation of the Norwegian Surveillance System for Communicable Diseases (MSIS) in 1994,
involving GPs and microbiological laboratories, suggested that the system has a high coverage,
capturing over 90% of patients diagnosed with gonorrhoea.
Methods: Using MSIS data on gonorrhoea cases we analysed specific trends by route of
transmission, age, gender, anatomical sampling site, antimicrobial resistance and travel history from
1993–2007 and, to focus on more recent trends, from 2003–2007. MSM and heterosexual cases
were defined by route of transmission.
Results: From 1993 to 2007, 3601 gonorrhoea cases were reported. MSM cases increased from
10 in 1994 to 109 cases in 2004. From 2003–2007, the incidence of gonorrhoea was 5.4/100,000
person-years (95%CI: 4.9–6.0). Over these five years, MSM accounted for an average of 80 cases
per year, of which 69% were infected by casual partners. In the same period, 98% of heterosexually
infected had a positive swab from urethra only and only two (0.3%) from the pharynx. Only one
woman (0.5%) was positive from the rectum. From 1993 – 2007, antimicrobial resistance results
were reported for 3325 N. gonorrhoeae isolates (98% of cultured samples). The proportion
resistant to quinolone has risen from 3% in 1995 to 47% in 2007, with 81% of the latter isolated
from patients infected in Asia.
Conclusion: The overall incidence of gonorrhoea in Norway remains low, but the increasing
number of MSM cases calls for new, more effective approaches to prevention. Infections originating
from abroad represent a constant risk of importing antimicrobial resistant N. gonorrhoeae. Due to
the prevalence of quinolone resistant N. gonorrhoeae in Norway, third-generation cephalosporins
should replace quinolones as the first choice in treatment guidelines. We advocate antimicrobial
susceptibility testing for all cases and recommend taking samples for culture from all exposed
anatomical sites.
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Background
Gonorrhoea, a bacterial infection caused by Neisseria gon-
orrhoeae, is a highly communicable [1] sexually transmit-
ted infection (STI) and, due to a short incubation period,
may serve as an indicator of recent risky sexual behaviour
in symptomatic cases [2]. Since the seventies, when gon-
orrhoea was at its peak, the number of cases has decreased
dramatically in many European countries [3,4]. Neverthe-
less, this preventable and treatable infection has been
reported to be on the rise in several European countries
[3,5] since the late nineties, particularly among men who
have sex with men (MSM) [6-10] and teenagers [3,6,8].
Patients with gonorrhoea may experience symptoms such
as purulent discharge and dysuria. The majority of hetero-
sexual men (95% and more) are symptomatic, whereas up
to 60% of women may be asymptomatic carriers of the
disease for as long as 12 months [1]. Pharyngeal and rectal
infections, which are mostly asymptomatic [1], may be
important in gonorrhoeal transmission among MSM [11].
The risk of acquiring pharyngeal gonorrhoea by oral-gen-
ital heterosexual contact has been reported to be 14% for
men and 31% for women [12]. Clinical trials reported
pharyngeal gonorrhoea to be self-limiting within three
months [13,14]. Untreated genital gonorrhoea may lead
to serious late complications such as pelvic inflammatory
disease, fistula formation and urethral strictures [1]. Fur-
thermore, gonorrhoea increases susceptibility to HIV and
HIV shedding in HIV positive patients [15].
Since the mid seventies, when penicillinase producing N.
gonorrhoeae (PPNG) was first reported [1], treating gonor-
rhoea has presented an ongoing challenge around the
world. In a sentinel surveillance study from 2004, signifi-
cant proportions of N. gonorrhoeae isolates from 12 West-
ern European countries were resistant to azithromycin,
ciprofloxacin, penicillin or tetracycline and as much as
22% were resistant to more than one of these antimicro-
bials [16].
In Norway, under the Infectious Disease Control Act, all
clinicians and laboratories are legally obliged to notify
gonorrhoea cases to the Norwegian Institute of Public
Health (NIPH). Using data from the Norwegian Surveil-
lance System for Communicable Diseases (MSIS), we
describe the epidemiology of gonorrhoea in Norway in
the last 15 years (including specific trends by route of
transmission, age, gender, antimicrobial resistance, place
of infection and anatomical sampling sites) in order to
develop targeted recommendations for the diagnosis, pre-
vention and treatment of gonorrhoea [17].
Methods
Cases fulfilling any of the following criteria should be
reported to MSIS: 1. the patient has clinical symptoms
compatible with gonorrhoea and is epidemiologically
linked to another case; 2. N. gonorrhoeae was proven in the
patient's sample by culture, antigen testing or nucleic acid
amplification technique (NAAT) or 3. direct Gram-stained
smear for microscopy shows intracellular diplococci. The
case definition did not change during the study period. All
clinicians and all of the approximately 20 clinical micro-
biology laboratories in Norway report to the system [18].
The Norwegian population during the study period was
approximately 4.5 million.
Upon confirmation of a case of gonorrhoea, the labora-
tory sends a notification to the NIPH and a blank report-
ing form to the patient's clinician. The clinician fills the
form with additional clinical and epidemiological data
about the patient and sends it to the NIPH. All reports are
anonymous and linked with a unique non-identifying
number. NIPH uses laboratory reports to identify and
remind clinicians if they fail to report on a case. The sys-
tem achieves coverage of about 90% [18,19] and the data
is of high quality; missing variables are rare. Most of the
cases are initially reported by the laboratories; however, a
minority of cases is reported directly from two venereal
disease clinics and clinicians if direct microscopy of
Gram-stained smear is used for establishing the diagnosis.
Among the key data collected by the surveillance system
are: sex of the patient, date of sampling, month and year
of birth, country of residence, country of birth, country of
infection, reporting laboratory, type of diagnostic test
used, anatomical sampling site, susceptibility of N. gonor-
rhoeae to antimicrobials, reasons for testing, transmission
route and relation to the source person.
For the purpose of this study, we defined MSM cases as
men who acquired gonorrhoea infection from another
man (homosexual transmission). Similarly, we defined
heterosexual cases as persons who acquired gonorrhoea
infection from a partner of the opposite sex.
Reporting of PPNG was introduced in MSIS in 1993,
while reporting of quinolone resistance started in 1995.
No other resistance is currently reported in MSIS. Labora-
tories test all strains for penicillinase (betalactamase) pro-
duction and for susceptibility to the most relevant
antimicrobials, but the methods may vary by laboratory.
We analysed the data on all cases reported to MSIS from
1993 to 2007 by using Microsoft Excel and Stata 9.0. To
describe more recent trends, we analysed data over a five
year period from 2003 to 2007. We described cases
according to demographic characteristics and various risk
factors, including self-reported travel history and trans-
mission route. The annual incidence with a 95% confi-
dence interval (CI) was calculated using yearly population
estimates by Statistics Norway http://www.ssb.no. We
used Prais-Winsten autoregression to evaluate linear
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trends in all studied data over time, taking into account
autocorrelation.
Results
From 1993 to 2007 NIPH received 3601 reports of gonor-
rhoea cases diagnosed in Norway (Figure 1). The number
of diagnoses decreased from a high in 1993 of 346 cases
(8.0 per 100,000 population) to a low in 1998 of 166
cases (3.8 per 100,000 population). Cases peaked again in
2001 with 327 reports, of which 290 (89%) were diag-
nosed by culture and 35 (11%) by the newly available
NAAT. The mean incidence in the recent five-year period
(2003–2007) was 5.4 per 100,000 person-years (95% CI:
4.9–6.0). The sexual transmission route was reported for
3578 (99.4%) cases from 2003 to 2007 (Table 1).
Demographic data and groups by transmission route
In the years 2003 to 2007, among teenagers (10 to19
years) females represented the majority of heterosexually
transmitted cases (Table 1). Between 1993 and 2007, the
number of cases among all teenage cases did not increase
significantly (p = 0.100); however we did observe a con-
current increase among those aged 45 years and older in
all transmission groups (p = 0.001), from 13 cases in 1993
to 48 cases in 2007. The median age among heterosexu-
ally infected men and women has increased since the early
nineties (p < 0.001 for both), while the median age of
MSM has remained relatively stable at around 29 years (p
= 0.043) (Figure 2).
The majority of cases occurred in those born in Norway,
although cases among migrants and visitors from other
European countries and Asia are represented, especially
among heterosexuals (Table 1).
In the period from 1993 to 2007, 842 MSM were diag-
nosed with gonorrhoea; from a low of 10 (4% of all cases)
in 1994 to a high of 109 cases (41% of all cases) in 2004
(Figure 1). We observed a linear increase in the number of
cases (p < 0.001) in this group during the study period,
with an average of 80 cases per year since 2003. The
majority resided in Oslo city and acquired their infection
Number of gonorrhoea cases by major transmission routes in Norway (N = 3578), 1993–2007Figur  1
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Table 1: Selected characteristics of sexually infected gonorrhoea cases reported to the Norwegian surveillance system for 
communicable diseases (N = 1257), 2003–2007.
Characteristic Selected categories Sexual transmission route
Heterosexual Homosexual Unspecified
Women
n = 185 (%)
Men
n = 645 (%)
Men
n = 405 (%)
Men
n = 22
Age Median age in years 27 34 31 41
10–19 years 32 (17) 25 (4) 20 (5) 0
20–24 years 42 (23) 80 (12) 64 (16) 1
25–34 years 59 (32) 216 (33) 160 (39) 5
35–44 years 33 (18) 188 (29) 110 (27) 7
t 45 years 19 (10) 136 (21) 51 (13) 9
Residence Oslo city 64 (35) 229 (35) 310 (76) 13
Other 121 (65) 416 (65) 95 (23) 9
Origin by birthplace Norwegian 131 (71) 505 (78) 350 (86) 21
European, other 16 (9) 51 (8) 32 (8) 0
Asian 23 (12) 60 (9) 8 (2) 0
African 6 (3) 22 (3) 5 (1) 1
Other 9 (5) 7 10 (2) 0
Reason for visiting Norway Temporary visit to Norway 15 (8) 19 (3) 13 (3) 0
First generation immigrant 16 (9) 65 (10) 22 (5) 1
Other, including permanent residents 154 (84) 561 (87) 370 (91) 21
Place of infection Infected abroad 55 (30) 364 (56) 62 (15) 2
- In Thailand 14 (8) 155 (24) 3 (7) 0
Infected in Norway 124 (67) 274 (43) 341 (84) 15
- In Oslo 47 (2) 145 (22) 294 (73) 13
Unknown 6 (3) 7 (1) 2 (0.5) 5
Source partner Steady partner 74 (40) 90 (14) 81 (20) 3
Casual partner 84 (45) 388 (60) 280 (69) 4
Prostitute 0 109 (17) 1 (0.2) 0
Other 8 (4) 14 (2) 19 (5) 0
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there (Table 1). In these five years, the proportion infected
by casual partners varied from 60 to 80%.
Since 1996, the ratio of heterosexual men to women,
infected with gonorrhoea in Norway, remained above 2
(Figure 3). Since 1993, symptoms were a reason for testing
in 61% of infected women compared to 93% in men. The
median duration of symptoms before sampling was four
days for men and eight days for women. Between 2003
and 2007, 40% of the women got infected by steady part-
ners compared to 14% of heterosexual men (Table 1).
Anatomical locations of positive samples
From 1993 to 2007, 2677 (75%) of all cases were positive
from a urethral swab. Of 91 patients diagnosed from a
pharyngeal swab, 70 (77%) were MSM, 13 were women
and eight were heterosexually infected men. Of 190 cases
diagnosed from a rectal swab, 171 (90%) were MSM and
19 were female; among the females four had samples pos-
itive both from rectal and endocervical swabs. The
number of positive rectal swabs in women has declined to
one or less per year since 2001. From 2003–2007, no het-
erosexually infected man had gonorrhoea confirmed from
more than one anatomical site (Table 2).
Antimicrobial resistance
From 1993 to 2007, 3399 cases (94%) were diagnosed by
culture. In 2001, culturing was used in 89% of the cases,
the lowest proportion in the entire period. Antimicrobial
resistance was reported for 3325 (98%) of all cultured N.
gonorrhoeae isolates. From 2003 to 2007, there has been a
marked increase in the number of isolates reported to be
quinolone resistant only, or both PPNG and quinolone
resistant (Figure 4). Quinolone resistance is mainly found
in isolates from patients infected in Asia. Among these
patients, the proportion of quinolone resistance rose from
8% in 1998 to 81% in 2007.
Imported gonorrhoea
In the early nineties, 70% of the cases reported acquiring
their infection in Norway. This proportion decreased to
around 60% in 2005 and 2006. Patients that reported
unsafe sex during a recent travel to a foreign country prior
to diagnosis, i.e. "imported gonorrhoea", were predomi-
nantly heterosexual men (80%). In 1993, 26% of the het-
erosexual infections among men were acquired outside
Norway, compared to 62% in 2007. From 2003 to 2007,
between 30 and 45 cases have been imported from Thai-
land to Norway every year. In 2003, 29% of all heterosex-
ual male cases had been infected in Thailand. Other cases
originated from around the world, with up to eight cases
per year per country acquired in Pakistan, the Philippines,
Brazil, Spain and Indonesia. Among those infected
abroad, travellers aged 45 years and older represented
21% and those in the age group 35–44 years represented
30% in the period from 2003 to 2007.
Discussion
The incidence of gonorrhoea in Norway from 2003 to
2007 (5.4 per 100,000 person-years) is similar to Sweden,
Unknown 18 (10) 44 (7) 24 (6) 15
Indications for testing Symptoms 114 (62) 631 (98) 331 (82) 20
Contact tracing 34 (18) 10 (1) 26 (6) 0
Own request 14 (8) 2 (0.3) 13 (3) 0
Blood donor 1 (0.5) 1 (0.2) 0 0
Pregnancy 1 (0.5) / / /
No specific reason 21 (11) 1 (0.2) 35 (8) 2
Diagnosed by General practitioner, private specialist 90 (49) 384 (59) 119 (29) 21
STI clinic 51 (28) 215 (33) 267 (66) 0
Hospital 24 (13) 13 (2) 5 (1) 0
Youth clinic 12 (6) 15 (2) 6 (1) 0
Other 8 (4) 18 (3) 8 (2) 1
Table 1: Selected characteristics of sexually infected gonorrhoea cases reported to the Norwegian surveillance system for 
communicable diseases (N = 1257), 2003–2007. (Continued)
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Finland and Denmark and much lower than in the UK
[20], making gonorrhoea a rare disease in Norway. How-
ever, several important challenges remain to be faced.
The majority of gonorrhoea cases are among heterosexual
men, but because we lack a population denominator to
calculate the incidence among MSM, it is not possible to
conduct a proper comparison among the transmission
groups. Nevertheless, we can conclude that MSM are cur-
rently the most vulnerable population to gonorrhoea
infection in Norway and that preventive measures against
STIs [21] among MSM are failing in Norway, similar to
observations in other countries [8-10,22,23]. The rising
trend of gonorrhoea among MSM is of particular concern
as the proportion of cases infected through a casual part-
ner is high, indicating increased risk for other STIs, includ-
ing HIV. The majority of MSM get infected with
gonorrhoea in the capital Oslo; therefore, preventive
measures should be particularly focused on this area.
Among heterosexual cases, the median age is increasing.
This may be due to the increasing age of the same risk group
over time or the fading effect of preventive programmes pri-
marily targeted at the young. Middle-aged men may be
more able and willing to afford sex tourism in the areas of
the world where gonorrhoea is still prevalent (see below).
Based on similar observations of an increasing trend in
reported gonorrhoea infections among people 45 years old
and older, the need for interventions, aimed specifically at
this group, has also been emphasised in the UK [24].
Median age of patients with gonorrhoea in Norway by major transmission routes (N = 3578), 1993–2007Figure 2
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Among 21 European countries with diverse surveillance
systems, Norway had the eighth highest men to women
ratio of gonorrhoea cases in 2006 [20]. Among heterosex-
ually acquired domestic cases, the number of males diag-
nosed is 2 to 3 times greater than females, similar to
reports from other countries [6,9]. Reasons for this gender
disparity may include: behaviour differences (promiscu-
ity, visiting prostitutes, partner notification etc.), biologi-
cal differences in developing symptoms, duration of
infection and a pool of undiagnosed cases among asymp-
tomatic women. Since women are more susceptible to
infection [1] and frequently experience an asymptomatic
course of infection, the persistence of endemic gonor-
rhoea in Norway might be fostered by undiagnosed
women. The gender ratio implies that a more thorough
approach to contact tracing is warranted; however this is
limited by the frequency of infections in heterosexual
men associated with casual partners or prostitutes (Table
1), making partner notification difficult. Since symptoms
were stated as a reason for testing in only 60% of women,
we can conclude that asymptomatic cases are being diag-
nosed with gonorrhoea as well.
While gonorrhoea has become rare in Norway, it should
still be considered as a diagnostic option. When making
decisions for testing, clinicians should be aware that many
women in Norway, similar to reports from other countries
[9,25], acquire their infection from a steady partner, hav-
ing no obvious risk-factors for gonorrhoea in their medi-
cal history. Furthermore, belated diagnosis might lead to
severe health complications as we experienced in a recent
gonorrhoea outbreak in Norway in 2008 [26].
The number of samples tested with a negative result in
Norway is unknown. There is little evidence whether sam-
pling from several anatomic sites increases the diagnostic
sensitivity [27], but studies among MSM show that sam-
pling from the urethra only may lead to a significant pro-
portion (up to 40%) of missed cases [22,28,29].
Regardless of the exposure, rectal co-infection with cervical
Ratio of heterosexual men to heterosexual women, infected with gonorrhoea; domestic cases only (N = 1637), Norway, 1993–2007Figure 3
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gonorrhoea has been reported in up to 30% of infected
women [1], therefore the low number of women who
recently tested positive from the rectum (Table 2) may sug-
gest that rectal samples from women are rarely taken. In a
study in France, a prevalence of 6% of pharyngeal gonor-
rhoea among heterosexual men with urethral gonorrhoea
has been reported from 1999 to 2001 [23]. To tackle the
possible undiagnosed reservoir of infection, it is important
that sampling is carried out according to the exposures
rather than the presence of symptoms; although some
patients might be reluctant to provide the details of their
exposure (see "Unspecified" group, Table 2).
Antimicrobial resistant N. gonorrhoeae is an increasing
problem in Norway, exacerbated by a large proportion of
imported infections from Asia. Following their importa-
tion into Norway and subsequent onward spread within
the population, infections originating abroad are not eas-
ily identifiable [26]. Recently reported travel is not a reli-
able tool to guide treatment choices. More than 40% of
infections in 2006 and 2007 were quionolone resistant,
regardless of whether they were acquired domestically or
abroad (Figure 4), which implies that third generation
cephalosporins should replace quinolones as the first
choice empirical treatment for gonorrhoeal infections in
the Norwegian treatment recommendations [30]; similar
to recent recommendations in other countries [31,32]. As
resistance to third generation cephalosporins is already
emerging [16], improved surveillance of N. gonorrhoeae
resistance, involving reporting resistance to any relevant
antimicrobial, using nationally standardized methods, is
necessary for the timely review and revision of national
treatment guidelines. This may help to ensure that the
most clinically effective empirical treatments, ideally
achieving a cure rate of over 95% [33], will be used in the
future. This is feasible in Norway due to the prevalent
practice of diagnosing gonorrhoea with culture and a high
coverage of reporting to MSIS.
Although travellers who got infected with gonorrhoea rep-
resent a diverse group, some studies identified demo-
graphic factors such as male sex, single status and age of
<20 years [34] as associated with a higher frequency of
casual sexual intercourse abroad, while others identified
Table 2: Anatomical sites of N. gonorrhoeae isolates, reported to the Norwegian surveillance system for communicable diseases (N = 
1257), 2003–2007.
N. gonorrhoea isolated from*: Sexual transmission route
Heterosexual Homosexual Unspecified
Women
n = 185 (%)
Men
n = 645 (%)
Men
n = 405 (%)
Men
n = 22
Urethra 8 (4) 631 (98) 276 (68) 22
Cervix 143 (79) / / 0
Rectum 0 0 68 (17) 0
Pharynx 7 (4) 2 (0.3) 20 (5) 0
Urethra, rectum and pharynx 1 (0.5) 0 4 (1) 0
Urethra and pharynx 0 0 7 (2) 0
Rectum and pharynx 0 0 8 (2) 0
Rectum and urethra 0 0 15 (4) 0
Cervix and pharynx 1 (0.5) / / 0
Cervix and urethra 19 (10) / / 0
Other, unspecified 3 (2) 4 (0.6) 1 (0.2) 0
Unknown 3 (2) 8 (1) 6 (1) 0
* the categories are mutually exclusive
BMC Infectious Diseases 2009, 9:33 http://www.biomedcentral.com/1471-2334/9/33
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middle-aged and married travellers [35] as high-risk
groups. It is therefore interesting to note that male travel-
lers, older than 45 years, represent a significant propor-
tion among our cases and that as much as half of the
infected travellers are older than 34 years.
Among all the infections acquired outside of Norway,
Thailand, a known sex tourism destination [34] remains
the most prominent country associated with the acquisi-
tion of gonorrhoea since the nineties [36], especially
among heterosexual men. A similar situation has been
described in Denmark and Sweden [6,9]. Due to the high
prevalence of HIV infection in Thailand, the rise of
imported gonorrhoea is a stark reminder of the high-risk
sexual behaviour of some Norwegian travellers. Asympto-
matic travellers who had casual sex abroad rarely present
at the doctor's office, therefore screening for STIs might
not be possible [34].
We identified some potential limitations and weaknesses
of our study. The evaluation of the STIs reporting coverage
to MSIS was done more than a decade ago. All behav-
ioural data in the system are self-reported. As the spectrum
of collected variables in Norway is rather broad, some
missing data were noted. We defined MSM and heterosex-
ual cases according to the reported route of transmission.
This definition provides no insight into the actual sexual
orientation, behaviour or sexual practices of the patients
and is only related to a single exposure, at which patients
got infected. Culturing of N. gonorrhoeae, a method most
frequently used for laboratory confirmation of gonor-
rhoea in Norway, has specificity of 99% and sensitivity of
60 to 70% [37], which might be further affected by trans-
port conditions. Therefore, a negative laboratory sample
does not exclude gonorrhoea. Patients with negative tests
should still be reported, providing they experience clinical
symptoms compatible with gonorrhoea and are epidemi-
ologically linked to another case. In this scenario, report-
ing should arise from the clinicians' initiative; however no
such cases were reported during the entire period from
1993 to 2007. This could indicate that a small proportion
of gonorrhoea infections in Norway remain unreported.
Proportion of PPNG and quinolone resistance of 3399 cultured isolates of N. gonorrhoeae Norway, 1993–2007Figure 4
Proportion of PPNG and quinolone resistance of 3399 cultured isolates of N. gonorrhoeae Norway, 1993–2007. 
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Although clinicians are strongly encouraged to obtain a
sample for culturing, some may skip reporting of cases
diagnosed with direct microscopy. Nevertheless, we con-
sider MSIS a representative and reliable source of data on
gonorrhoea cases in Norway.
The observed peak incidence in heterosexual cases in
2001 was partially influenced by the decision of one lab-
oratory to screen samples collected for Chlamydia testing,
with NAAT for both Chlamydia and gonorrhoea. In 2001,
this laboratory reported 46 cases in total – much higher
than in the previous (4 cases) and the following year (17
cases). Using NAAT for screening in low prevalence popu-
lations has been associated with lower positive predictive
value [38] and some of the reported cases might have
been false positive. This laboratory continued to use
NAAT in the following years and reported it as the diag-
nostic method in 75% of cases. Nevertheless, the peak in
2001 remains prominent even after excluding the cases
diagnosed with NAAT, and is largely due to heterosexual
cases infected in Norway. No increase in HIV and syphilis
was observed in this group at the same time or a year later
[17].
Conclusion
The overall incidence of gonorrhoea in Norway is low.
Heterosexual transmission is fairly stable, while there is a
worrisome increase among MSM. Since most of the MSM
report getting infected in Norway (Oslo), prevention
efforts at local MSM venues should continue. Further
research is necessary to identify more effective prevention
measures and reasons for the resurgence of STIs among
MSM Europe-wide. Gonorrhoea is frequently brought to
Norway from abroad with a higher risk of imported cases
being resistant to antimicrobials. As the link to the foreign
country might be lost soon after the introduction to Nor-
way, the widespread practice of culturing which enables
antimicrobial susceptibility testing should be further
encouraged. There is a need for standardisation of
national laboratory methods for susceptibility testing and
for improving the surveillance of antimicrobial resistance
to enable rapid revision of treatment guidelines when nec-
essary. We recommend taking samples for culture of N.
gonorrhoeae from all exposed anatomical sites.
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Research articleSyphilis epidemiology in Norway, 1992-2008: 
resurgence among men who have sex with men
Irena Jakopanec1, Andrej M Grjibovski1,2,3, Øivind Nilsen1 and Preben Aavitsland*1
Abstract
Background: In recent years, the number of syphilis cases has stabilised in many countries of Western Europe, 
however several countries have reported increases among men who have sex with men (MSM). The aim of this article 
was to describe the epidemiology of early syphilis in Norway in 1992-2008.
Methods: Cases of early syphilis and congenital syphilis reported to the Norwegian Surveillance System for 
Communicable Diseases (MSIS) 1992-2008 were described by route of transmission, gender, age, birthplace, stage of 
disease, HIV co-infection, source partner and place of infection.
Results: The incidence of reported syphilis ranged from 0.05 (1992) to 1.50 (2002) per 100 000 person-years. Of 562 
cases reported to MSIS during the study period, 62% were men infected by another man. The proportion of those, 
infected homosexually increased from 0 (1992-1994) to 77% (2008). Most of them were Norwegians (83%). The 
proportion of HIV co-infection among homosexually infected increased over time and reached 39% in 2008. The 
majority reported being infected by a casual partner (73%) and in the municipality of Oslo (72%). Of 152 heterosexually 
infected men 64% were Norwegians; 51% were infected by casual contacts and 20% by commercial sex workers; 73% 
were infected abroad. Among 56 women, 57% were Norwegians, 57% were infected by a steady partner and 40% were 
infected abroad. Almost half (46%) were diagnosed in the early latent stage. Four cases had congenital syphilis, two of 
whom were adopted from abroad.
Conclusions: Syphilis is rare in Norway, but MSM represent almost two thirds of cases. The increase of HIV co-infected 
cases among MSM may enhance transmission of both infections. We recommend sexually active MSM to be tested for 
syphilis 2-4 times a year. Due to its variable clinical course, syphilis might be difficult to recognise at an early stage 
among women in a low-prevalence population. We estimate current practice of prenatal screening in Norway as 
sufficient.
Background
Following increases in the early 2000s in Western Euro-
pean countries, the number of reported syphilis cases has
recently stabilised; however many countries reported a
high proportion of homosexually acquired syphilis
(France, Denmark, Ireland, Germany, UK, Sweden, Neth-
erlands) [1]. Increases among men who have sex with
men (MSM) have been reported worldwide [2] and a sig-
nificant proportion of them have been found to be co-
infected with HIV [3,4].
Infectious stages of syphilis are primary, denoted by a
painless ulcer in about one third of patients, and second-
ary, with diverse symptoms. Patients in the latent stage
are seemingly unaffected, but about 25% may experience
relapses to secondary syphilis during the early latent
stage (i.e. less than a year since infection) [4,5]. Vertical
transmission may result in congenital syphilis, difficult to
recognise in seemingly asymptomatic newborns [6].
Untreated, syphilis may result in death and serious dis-
ability [4,5], however effective penicillin-based treatment
is inexpensive. Testing and treatment are free of charge in
Norway.
Serological tests for syphilis lack sensitivity and though
some may be helpful in assessing the stage of infection,
they are unreliable [7]. In determining the stage, particu-
larly in asymptomatic patients, clinicians thus rely on
previously documented syphilis tests, anamnesis (i.e.
most likely time of exposure, data from contact tracing,
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known previous treatment) and clinical evaluation.
Uncertain stage in asymptomatic patients with unknown
duration of infection is an important limitation of early
syphilis (i.e. primary, secondary and early latent syphilis)
surveillance.
Using data from the Norwegian Surveillance System for
Communicable Diseases (MSIS), we describe the epide-
miology of early syphilis in Norway from 1992-2008.
Methods
Under the Infectious Disease Control Act, syphilis is a
mandatory notifiable disease, therefore all clinicians and
laboratories in Norway must notify all cases of newly
diagnosed syphilis anonymously to the MSIS, based at
the Norwegian Institute of Public Health (NIPH). Con-
tact tracing and notification, mandatory by the same act,
is the responsibility of the clinicians. Previously manda-
tory screening of pregnant women in Norway became
optional in 1995; however, virtually all pregnant women
are still tested. If a patient has a positive syphilis test,
screening for other sexually transmitted infections (STIs)
is recommended.
Upon a positive syphilis test, all 22 local laboratories in
Norway send their notification to both NIPH and the cli-
nician involved. Both of these notification forms carry the
same unique non-identifying number for an individual
patient. Having received notification from the laboratory,
clinicians fill out the corresponding clinical report on the
stage of the disease, patient's demographic data, symp-
toms, co-existing STIs, risk behaviour (including most
likely transmission route and time of exposure) and their
source partner, and send it to the NIPH. There, only one
co-existing STI can be entered into the MSIS database. If
the patient is reported to have an HIV infection, HIV is
always entered.
At NIPH, only newly recognised cases with early syphi-
lis, defined as laboratory confirmed, primary, secondary
or early latent syphilis (less than a year since infection)
are entered into the MSIS database. The reports on a sin-
gle patient from laboratories and clinicians are merged
using the unique non-identifying number. Every reported
case is individually evaluated at NIPH and clinicians can
be contacted if the stage of syphilis is unclear or if they
failed to report on a case, notified by laboratory only.
We used the following key variables from the reports:
route of transmission, gender, month and year of birth,
birthplace (country and continent), place of residence,
reason for being in Norway, indications for testing, dura-
tion of symptoms, stage of disease, co-existent STI, rela-
tion to the source person, place of infection and the type
of clinical practice where the diagnose was made. We also
studied differences between HIV co-infected and HIV
negative men, infected with syphilis homosexually. The
data were analysed in categories as presented in Table 1.
The data on all cases of early or congenital syphilis were
obtained from MSIS. The size of population used for cal-
culating incidence rate for each year was obtained from
Statistics Norway [8] and was about 4.5 million. We used
Stata 9.2 software (STATA Corp., TX, USA) for the analy-
sis. Simple linear regression analysis was used to estimate
trends over time. Given that the data between subsequent
years may be correlated and the variability between the
years may not be constant over time, the regression coef-
ficients and their 95% confidence intervals (CI) were cal-
culated using the Newey-West procedure. Bivariate
comparisons between groups were performed using
Pearson's chi squared test. Due to different mode of
transmission, cases of congenital syphilis were described
separately.
Results
From 1992 to 2008, 562 cases of syphilis diagnosed in
Norway were reported to MSIS, including four congenital
cases.
The incidence rate in the study period was 0.7 per 100
000 person-years (95% CI: 0.06-1.0); varying from 0.05
per 100 000 person-years in 1992 to 1.2 per 100 000 per-
son-years in 2008. A peak was observed in 2002 with a
rate of 1.5 per 100 000 person-years (Figure 1). On aver-
age, there was an increase of 3.8 cases each year (95% CI:
2.8-4.8, p for trend < 0.001). No sexually infected case was
younger than 15 years. Of the 502 (89%) men who were
infected sexually, 350 (70%) were MSM.
Men, infected homosexually
One man, infected homosexually in 1995, and 2 in 1998
were followed by a marked increase of 40 cases in 1999,
representing 75% of all reported cases (Figure 1). More
than a half (61%) of the total 350 cases were older than 34
years. The majority (76%) resided in Oslo and 83% were
born in Norway. Before testing, 71% had symptoms. The
largest proportion of cases was diagnosed in a secondary
stage (43%). Almost one quarter of these men were also
HIV positive (Table 1). The proportion of those co-
infected with HIV increased over time (p for trend <
0.001) and reached 39% in 2008 (Figure 2). This increas-
ing trend remained significant even if calculated from
1999, when HIV co-infected were first reported (p for
trend = 0.009). Most homosexually infected men were
infected by a casual partner (73%) and in Oslo municipal-
ity (72%), (Table 1). Among 69 infected abroad, 18 (5% of
all cases) were infected in Spain.
Men, homosexually infected with syphilis, who were
also HIV positive, were more likely to be residents of Oslo
(p = 0.001), being diagnosed with syphilis later in the
course of disease (primary vs. secondary or early latent, p
= 0.006) and in a hospital (p < 0.001) than HIV negative,
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Table 1: Selected characteristics of sexually infected cases with early syphilis reported to the Norwegian surveillance 
system for communicable diseases, absolute numbers, (N = 558), 1992-2008.
Characteristic Selected categories Sex P1* P2*
Women




n = 152 (%)
Homosexual
transmission
n = 350 (%)
Age Median age in years 26 37 37 / /
15-24 years 22 (39.3) 8 (5.3) 33 (9.4) 0.222 < 0.001
25-34 years 16 (28.6) 56 (36.8) 103 (29.4)
35-44 years 13 (23.2) 47 (30.9) 119 (34.0)
≥ 45 years 5 (8.9) 41 (27.0) 95 (27.1)
Residence Oslo municipality 16 (28.6) 55 (36.2) 266 (76.0) < 0.001 0.304
Other 40 (71.4) 97 (63.8) 84 (24.0)
Birthplace Norway 32 (57.1) 97 (63.8) 290 (82.8) < 0.001 0.773
Europe, other 8 (14.3) 20 (12.7) 28 (8.0)
Asia 11 (19.6) 24 (15.8) 12 (3.4)
Africa 3 (5.3) 9 (5.9) 6 (1.7)
Other 2 (3.6) 2 (1.3) 14 (4.0)
Reason for being 
in Norway
Temporary visit 0 2 (1.3) 9 (2.6) 0.546 0.644
First generation 
immigrant/adopted
5 (8.9) 16 (10.5) 30 (8.6)
Other, including 
permanent residents
51 (91.1) 134 (88.1) 311 (88.9)
Indications for 
testing
Symptoms 15 (26.8) 121 (79.6) 248 (70.8) < 0.001 < 0.001**
Contact tracing 17 (30.3) 12 (7.9) 29 (8.3)
Own request 1 (1.8) 5 (3.3) 25 (7.1)
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Routine testing of an 
immigrant
6 (10.7) 6 (3.9) 0
Pregnancy 13 (23.2) / /
No specific reason/
other
4 (7.1) 8 (5.3) 48 (13.7)
Median duration 











Stage of early 
syphilis
Primary 18 (32.1) 84 (55.3) 125 (35.7) < 0.001 < 0.001
Secondary 12 (21.4) 43 (28.3) 149 (42.6)
Early latent 26 (46.4) 25 (16.4) 76 (21.7)
Other reported 
STI****
none 52 (92.8) 140 (92.1) 239 (68.3) < 0.001 0.959
HIV 1 (1.8) 2 (1.3) 85 (24.3)
Chlamydia 1 (1.8) 4 (2.6) 16 (4.6)
gonorrhoea 0 0 3 (0.9)
herpes 0 2 (1.3) 3 (0.9)
hepatitis B 1 (1.8) 2 (1.3) 3 (0.9)
other 1 (1.8) 2 (1.3) 1 (0.3)
Source partner Steady partner 32 (57.1) 20 (13.1) 56 (16.0) < 0.001 < 0.001
Casual partner 11 (19.6) 78 (51.3) 254 (72.6)
Commercial sex worker 0 31 (20.4) 0
Other/Unknown 13 (23.2) 23 (15.1) 40 (11.4)
Place of 
infection
Abroad Total abroad 23 (41.1) 111 (73.0) 69 (19.7)
Europe, other 8 (14.3) 43 (28.3) 57 (16.3) < 0.001***** 0.001*****
- In Russia 3 (5.4) 20 (13.1) 1 (0.3)
Table 1: Selected characteristics of sexually infected cases with early syphilis reported to the Norwegian surveillance 
system for communicable diseases, absolute numbers, (N = 558), 1992-2008. (Continued)
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Asia 9 (16.1) 34 (22.4) 4 (1.1)
Africa 3 (5.4) 11 (7.2) 2 (0.6)
South/Mid America 2 (3.6) 18 (11.8) 4 (1.1)
Other 1 (1.8) 5 (3.3) 2 (0.6)
Norway Total Norway 31 (55.4) 33 (21.7) 270 (77.1)
- In Oslo 7 (12.5) 17 (11.2) 244 (69.7)
Unknown 2 (3.6) 8 (5.3) 11 (3.1)
Diagnosed by General practitioner, 
private specialist
32 (57.1) 71 (46.7) 85 (24.3) < 0.001 0.440
Hospital 7 (12.5) 18 (11.8) 55 (15.7)
Youth/STI clinic 15 (26.8) 59 (38.8) 210 (60.0)
Other 2 (3.6) 4 (2.6) 0
*P-values for heterogeneity, using Pearson's chi squared test; P1 comparing homosexually and heterosexually infected men, P2 comparing 
women and heterosexually infected men
**Women diagnosed during pregnancy were excluded for comparison
*** Data available for 19 women, 109 men, infected heterosexually, and 199 men, infected homosexually
**** Only one co-infection can be recorded into the system: if reported, HIV is always recorded
***** Seven categories were compared, including: Norway, Europe-other, Asia, Africa, South/Mid America, other (abroad), and unknown
Table 1: Selected characteristics of sexually infected cases with early syphilis reported to the Norwegian surveillance 
system for communicable diseases, absolute numbers, (N = 558), 1992-2008. (Continued)
but they did not differ by age, birthplace, indications for
syphilis testing, source partner and place of infection.
Men, infected heterosexually
During the study period, 152 men were infected hetero-
sexually. No obvious time trend was observed (p for trend
= 0.158). More than half (57%) were older than 34 years.
Most (64%) were Norwegian, with a notable proportion
reporting a birthplace in Asia (16%). The majority (80%)
reported symptoms and their infection was mostly dis-
covered in the primary stage. Two men were HIV posi-
tive. Casual contacts and commercial sex workers (CSW)
were the source of infection in 71%. Most acquired their
infection abroad (73%) (Table 1); predominantly in Russia
(13%), Pakistan (10%), Brazil (7%) and Thailand (6%).
Most Norwegians were infected abroad, mainly in other
countries of Europe (36%), Asia (18%) and South and Mid
America (16%). Immigrants were mainly infected during
travels back to their continent of birth.
Women
Among 56 women reported to be infected with syphilis
from 1992-2008, 68% were younger than 35 years. Most
of the cases were Norwegian (57%) and 55% acquired
their infection in Norway. However, out of 31 infected in
Norway, 14 reported their male partner had been
infected abroad. Contact tracing was the predominant
cause for testing in women (30%), followed by symptoms
(27%) and pregnancy (23%). Almost half (46%) of all cases
were discovered in the early latent stage of disease. STI
co-infections were rare (Table 1). Women reported a
steady partner as the source of infection in 57%.
Children with congenital syphilis
The age of the four patients with congenital syphilis at the
time of diagnosis ranged from one to five years, one of
them was a boy. Two of these children were adopted from
abroad. The biological mother of one child was born in
Norway, but acquired her infection abroad, while the
mother of the other child was infected in Norway and
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tested positive with her second pregnancy in 2003, when
the affected child was five years old.
Discussion
Syphilis is a rare disease in Norway. However, since 1999,
there has been a resurgence among MSM, disproportion-
ately affecting HIV positive men. The epidemic among
MSM is mainly concentrated in the capital Oslo. Up to
73% of heterosexual men and 41% of women reported
being infected abroad. Compared to men, women seem
to be more frequently diagnosed as late as the early latent
stage and are diagnosed predominantly by contact trac-
ing. Men infected heterosexually reported being infected
by casual partner or a CSW in 71% of cases, as opposed to
women, who appear to be mostly infected by their steady
partners.
One of the strengths of our study is a probable high
coverage of diagnosed patients in MSIS [9,10] due to dou-
ble notifications from both laboratories and clinicians
and a long tradition of reporting among the latter. A large
set of variables on each patient is available; allowing for
demographic and behavioural insight.
Our study is subject to several limitations. Due to the
clinical course of this disease, some infected may stay
undiagnosed. Others, discovered by routine testing and
possibly asymptomatic, need to be evaluated by a clini-
cian for stage. We cannot completely exclude, however,
that some patients, reported as "early latent syphilis" may
have been infected longer than a year. This would partic-
ularly affect data on women in our study. Contrary to
this, every year, about hundred cases are only lab-
reported. Clinicians are aware we only include new cases
of early syphilis in the database, as we publish this infor-
mation in a yearly national MSIS report [11]. Contrary to
our experience with gonorrhoea with high reporting from
both laboratories and clinicians [9], clinicians may opt
out from sending in their part of the reporting form for
syphilis, if the person has been infected for more than a
year or has been known to have a positive test from
before. If the stage is unknown or in cases, only reported
by the laboratories, internal evaluation at NIPH includes
the testing sites (asylum centres), the immigrant status
and unknown date of exposure of most of these cases, to
determine the likelihood of late syphilis, however it may
happen there are some missed early cases among them.
Clinicians may also be contacted by NIPH to verify infor-
mation. Furthermore, behaviour data is subject to
response and recall bias. Data in a few variables are fre-
quently missing, including co-infection data. We believe,
however, that reporting is reliable on HIV co-infection.
Capacity for entering several co-infections at a time
should be improved in MSIS. The fact that hardly any
cases were reported as homosexually acquired until 1999
cannot be explained by changes in the notification system
or improved sexual behaviour reporting as in compari-
son, 10-42 cases of homosexually acquired gonorrhoea
per year were reported in the same time period and in the
same surveillance system [12].
Among European countries with various systems of
syphilis surveillance, the highest incidence rates for early
syphilis in 2007 (per 100 000 person-years) were reported
from: the UK (4.4, primary and secondary stages only),
Czech Republic (4.0), Sweden (2.6, less than two yeas
since infection), Germany (2.5) [1,13]. At NIPH, no total
counts of reported syphilis cases are kept, but late latent
probably represent a majority (more than 50%). In the
period from 2002-2007, late cases represented 50-73% of
all reported cases in Czech Republic, 35-51% in Germany
and 24-50% in Slovenia [1].
Compared to infected women in our study, heterosex-
ual men were older, more likely to be diagnosed in a pri-
mary stage and to report symptoms, and less likely to be
diagnosed through contact tracing. Similar findings were
reported from a London-based study [14]. Men are more
likely than women to report having been infected abroad,
which resembles the situation in Sweden, however
women in Sweden acquired their infection abroad more
frequently and had a higher median age (33 years) than
women in Norway [13]. A prevalence of HIV co-infection
among heterosexuals, much higher than in our study
(from 6-13%), has been reported from London and
France [14,15]. Compared to London with 12% of hetero-
sexual men reporting being clients of CSW [14], a higher
proportion of men in Norway used commercial sex ser-
vices, however they did so mostly abroad.
Similar to many other European countries [16], the epi-
demics among MSM in Scandinavia are mainly concen-
trated in men above 30 in metropolitan areas [13,17]. A
high, but stable proportion of syphilis and HIV co-infec-
tions among MSM in several countries has been ascribed
to serosorting, practice of oral sex and compromised
immune system [14,17,18]. While information on co-
infection is not always available, others have also reported
a simultaneous increase of HIV and syphilis among MSM
from 2000-2005 [19,20]. HIV positive MSM were also less
likely to be in the primary stage of syphilis when diag-
nosed as reported from London Enhanced Syphilis Sur-
veillance programme (2001-2004) [14].
The increase of pharyngeal, frequently asymptomatic
STIs among MSM has been associated with the practice
of unprotected oral sex, which is perceived as low risk for
HIV transmission [12,18,21]. This might explain the dif-
ferences in syphilis stage at the time of diagnosis between
homosexually and heterosexually infected men, as initial
painless lesion ("chancre"), appearing in the oropharynx
(as well as the rectum) may pass unnoticed among MSM.
Differences in syphilis stage between serodiscordant
homosexual men may be explained by potentially asymp-
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tomatic disease among the HIV positive [19] and a possi-
ble overlap of the primary and secondary stage [4].
Genital ulcers, including syphilitic chancre, can facilitate
HIV acquisition and transmission [22], which may,
together with frequent partner exchange, explain a simul-
taneous increase of both infections among MSM.
Compared to official population data, foreign-born
people are over-represented among syphilis cases in Nor-
way [23]. The reason could be opportunistic testing of
immigrants originating from countries with higher syphi-
lis prevalence. Occasional increases of syphilis cases,
linked to CSW, refugees/asylum seekers, immigrants
from the eastern Europe, especially Russia, or travelling
to these regions, were reported by several countries
(Czech Republic, Slovenia, Finland, UK) [24-26]. In Nor-
way, only sporadic syphilis cases related to Russia with
limited secondary transmission were noted [27]. It needs
to be emphasized, however, that sexual contact abroad is
a key risk factor for heterosexually-acquired syphilis in
Norway.
Whether or not a proportion of reported cases with late
syphilis represents a public health problem we should
further focus on in Norway, is debatable. As noted, the
majority of these cases are immigrants from countries
with high syphilis prevalence and were infected in coun-
tries of their origin many years ago. On the other hand,
mild, unspecific and painless syphilis symptoms make it
difficult to diagnose the disease early, especially in
women or MSM, who may not notice initial lesions in dif-
ficult-to-visualise areas [4]. The rarity of the disease in
Norway makes it a diagnostic challenge. It is therefore
important to focus diagnostic efforts on specific popula-
tion groups such as MSM and immigrants and, to find
women cases, to conduct thorough contact tracing.
An evaluation of the recommendations for yearly syph-
ilis testing of HIV positive MSM in the Netherlands
revealed up to third of infections were asymptomatic and
only discovered by screening [19]. Clinical care of HIV
positive MSM, such as CD4 T cell count or HIV viral
load, can conveniently include syphilis testing [28]. We
recommend that the epidemic of syphilis among MSM,
concentrated in Oslo, be tackled by enhanced syphilis
testing for sexually active MSM, whenever they present at
the STI clinic or at a general practitioner, ideally 2-4 times
a year [29].
The evidence for cost-effectiveness of prenatal screen-
ing policy in a very low-risk population (< 1%) seems to
be contradictory [30] and universal screening does not
prevent mothers from being infected later in the preg-
nancy. We estimate current recommendations and prac-
tice in Norway as sufficient.
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Conclusions
In summary, syphilis in Norway is mainly transmitted
among MSM in Oslo. Increasing co-infection with HIV in
this group underlines the need for enhanced screening
and prevention programmes. We recommend sexually
active MSM to be tested 2-4 times a year. Among hetero-
sexuals, coincidental import from other countries has
been observed, but further spread in Norway was limited.
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Abstract
Background: Recent reports on the growing HIV epidemic among men who have sex with men (MSM) in the EU/
EEA area were accompanied by an increase of reported HIV among MSM in Oslo, Norway in 2003. Our study with
data from 1995 to 2011 has described the recent trends of HIV among MSM in Norway and their socio-
demographic and epidemiological characteristics.
Methods: The data were collected from the Norwegian Surveillance System for Communicable Diseases. Cases
were described by age, place of infection, clinical presentation of HIV infection, STI co-infection and source partner.
We used simple linear regression to estimate trends over time.
Results: During the study period, 991 MSM, aged from 16 to 80 years, were newly diagnosed with HIV. No
significant trends over time in overall median age (36 years) were observed. Most of the MSM (505, 51%) were
infected in Oslo. In the years 1995-2002, 30 to 45 MSM were diagnosed with HIV each year, while in the years 2003-
2011 this increased to between 56 and 97 cases. The proportion of MSM, presenting with either AIDS or HIV illness,
decreased over time, while asymptomatic and acute HIV illness increased (p for trend=0.034 or less). STI co-infection
was reported in 133 (13%) cases. An overall increase of syphilis co-infected cases was observed (p for trend <0.001).
A casual partner was a source of infection in 590 cases (60%).
Conclusions: Though the increases described could be attributed to earlier testing and diagnosis, no change in the
median age of cases was observed. This indicates that it is likely that there has been an increase in HIV infections
among MSM in Norway since 2003. The simultaneous increase in STI co-infections indicates risky sexual behaviour
and a potential to spread both HIV and other sexually transmitted infections.
Keywords: HIV infection, Men who have sex with men, Epidemiology
Background
Increases in HIV transmission among men who have sex
with men (MSM) have recently been reported from sev-
eral continents [1], including Europe. Data from 13
Western European countries suggested an increase of al-
most 100% from 1999 to 2006 [2]. In 2008, sex among
MSM was the predominant mode of transmission of
HIV infection in the EU/EEA area, when persons,
infected in and originating from countries with
generalised HIV epidemics were excluded [3].
HIV infection has been a notifiable disease in Norway
since 1986 [4]. In the 1990s, the numbers of newly
reported HIV infections were relatively stable, but
Norway has experienced an increase in the number of
HIV infected since then. Up to the 31st December 2011,
heterosexual transmission was reported in 52% of all
reported cases and homosexual in 32% [5]. During this
time, immigration to Norway has greatly increased [6]
and immigrants, infected heterosexually in their country
of origin before arriving to Norway, now represent 36%
of all reported cases [5]. When it comes to transmission
of HIV in Norway, MSM have thus been the most vulner-
able population in the past decade. The first steep increase
of HIV infections among MSM in Oslo was noticed in
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2003, when 70% of the MSM cases diagnosed in 2003 were
infected that same year or the year before [7].
Over the past few years, we have observed that MSM
with newly diagnosed gonorrhoea or syphilis in Norway are
increasingly co-infected with HIV [8]. This is particularly
worrisome, as sexually transmitted infections (STI) might
increase both susceptibility to HIV infection and enhance
HIV transmission from HIV positives [9].
In order to gain a better insight into the development of
the HIV epidemic among MSM in Norway, we aimed to
describe the HIV diagnosed MSM over a seventeen year
period, using demographic and epidemiological data. Due
to an increase in HIV diagnosed MSM in 2003 [7], we were
especially interested to find the differences between those
MSM infected before 2003 and those infected after 2003.
Methods
Free HIV testing is available at various settings including
general practitioners, hospitals, youth clinics and STI clinics
in Norway and any HIV positive test has to be confirmed
through a reference laboratory. All five reference laborator-
ies are obliged, by law [10] to report positive results an-
onymously to the Norwegian Institute of Public Health
(NIPH) [4] when a new HIV diagnosis in Norway is con-
firmed. Then, a laboratory fills out a two-part reporting
form with a unique reference number. The laboratory sends
one part of the form to NIPH and the other part, carrying
the same reference number, to the referring clinician, who
provides more detailed data, including epidemiological data
of the patient to the NIPH. Clinicians are also obliged by
law [10], to conduct contact tracing for HIV. NIPH con-
tacts the clinicians who fail to submit their part of the form
within a month or who send an incomplete report [4].
This study is based on the Norwegian Surveillance Sys-
tem for Communicable Diseases database, managed at
NIPH. From the database, we extracted reports on males,
who reported being infected by another man (hereafter
MSM cases) and were diagnosed in the years 1995 - 2011.
Demographic data on each patient include gender, month
and year of birth, county of residence and country of birth.
A variety of epidemiological data are collected in addition,
such as: presumed transmission route, time and place of in-
fection, indications for HIV test, date of a previous (most
recent) negative HIV test, clinical presentation (AIDS was
defined according to the 1993 European AIDS definition in
the study population, [11]), relationship to the source part-
ner, place of infection, diagnostic site and STI infections,
concurrently existing with HIV infection diagnosed (STI
co-infections).
For our analyses, we grouped categories of source partner
“husband or cohabitant” (58 cases) and “steady partner”
(108 cases) into a common category of steady partners. Age
was grouped into four categories and county of residence
into four health regions. Immigrant background was
assigned to first and second generation immigrants and
those, adopted from abroad.
Among several potential co-existing STIs, only one is
recorded at NIPH, using hierarchical criteria (1. syphilis, 2.
gonorrhoea etc.). A HIV positive patient, who was also
positive for Chlamydia and early syphilis (primary, second-
ary and early latent stage), will thus only have early syphilis
recorded in addition to HIV.
A date of infection is estimated from laboratory results,
previous negative tests and patients’ information. If a previ-
ous negative HIV test date is the only information available,
date of infection is assigned as the midpoint of the period
between that test and the first positive test [4].
Cases with “probable” year of infection had been
diagnosed within three years and fulfilled the following cri-
teria: 1. exact date of infection was known, or 2. clinical
presentation as an acute HIV infection, supported by either
laboratory evidence (sero-conversion) or anamnestic data,
or 3. a negative test, no older than three years, was avail-
able, or 4. a clinician evaluated the anamnestic data on time
of infection to be reliable. If these additional criteria were
not fulfilled, but a date of infection was estimated, the cases
had “uncertain” year of infection.
Among 252 cases, where the available information did
not allow an estimate of the year of infection, we used clin-
ical presentation at diagnosis, assigning 10 years to those
with AIDS (median AIDS incubation time, N=53) and 3
months to those with acute HIV (N=1) [12], assigning all
these to the “uncertain” year of infection group. The
remaining 198 cases with asymptomatic HIV and HIV
illness were excluded from estimates of time gap between
year of infection and year of diagnosis.
We performed statistical analyses with Stata/SE 11.1
(Stata Corp., TX, USA). We calculated frequency distribu-
tion for descriptive analyses. We used linear regression ana-
lysis to estimate the trends over time (for STI co-infection
this was only possible for syphilis). Given that the data be-
tween subsequent years may be correlated and the variabil-
ity between the years may not be constant over time, the
regression coefficients and their 95% confidence intervals
(CI) were calculated using the Newey-West procedure.
In order to understand the differences between MSM,
infected with HIV earlier in our study period compared to
the period after the increase in 2003, we studied factors
associated with “diagnosed in the period 2003-2011”
(compared to diagnosed in the period 1995-2002) by
Poisson regression with robust variance estimates. Crude
and adjusted prevalence ratios (PR) with 95% CI were
calculated. If there was zero variance in a category, we
excluded this category from the analysis.
Results
In the period 1995-2011, 991 men, infected by another
man, were newly diagnosed with HIV infection in Norway.
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While no significant trend among cases was observed until
2002, the 2003-2011 period had a significant increasing
trend of HIV diagnoses among MSM (p for trend <0.001,
Figure 1).
The MSM were from 16 to 80 years old when diagnosed.
Overall median age was 36 years (range 33-38.5 years) and
interquartile range 30 – 44 years. No apparent trend in me-
dian age was observed, except for the period 1997 – 2002
(Figure 2).
Men with immigrant background represented 21% (205),
and men on a temporary visit to Norway, represented 4%
(37). Thus, a large majority were permanent residents of
Norway, mostly residents of Oslo municipality (666, 67%),
born in Norway (Table 1). The two other most frequent
countries of birth were Sweden (3%) and Thailand (3%).
Just above half of the cases (505, 51%) were infected in Oslo
and 140 (14%) in the rest of Norway.
For those who were infected abroad (248, 25%), predom-
inant countries of HIV acquisition were Thailand (34 cases),
Spain (33), USA (26 cases) and Germany (23 cases). Some
(109, 11%) could not identify where the infection was
acquired. Among those infected abroad, 39 had tested posi-
tive prior to arrival in Norway. Among 251 MSM, born
abroad, 105 acquired HIV infection abroad, compared to
143 out of 740 MSM, born in Norway. Their median age at
diagnosis was lower than for Norwegian born men (31
years vs. 38 years).
Half of the cases were infected less than a year prior
to being diagnosed (Table 1, Figure 1). The increase in
infections in 2003 and 2004 (Figure 1) coincides with an
increase of cases, infected by a casual partner (p for
trend <0.001) (Figure 3). The majority of cases were
asymptomatic at the time of diagnosis (597, 60%, Figure 4).
Furthermore, the proportion of MSM presenting with ei-
ther AIDS or HIV illness, decreased over time, however,
the proportion of both asymptomatic and those with acute
HIV illness increased (all with p for trend=0.034 or less).
Of the 133 (13%) cases with concurrent HIV and STI
infections, syphilis was reported in 50 (3%). Among the
remaining 83, 29 had gonorrhoea. Of those 54, who had
neither syphilis or gonorrhoea, 21 had hepatitis B, 16
had Chlamydia, 6 had genital warts, 5 had genital herpes
and 6 had ”other, unspecified STI”.
From 1995 to 1999, one HIV and syphilis co-infection
among MSM was reported (in 1998). In 2000, a year
after an outbreak of syphilis among MSM in Norway [8],
5 cases (15.6% of all HIV MSM cases that year) with co-
infection were reported. From 2001, the numbers of
HIV and syphilis co-infected MSM vary (0-9 cases, 0-9%
of all HIV cases), but there is an overall increase of syph-
ilis co-infected cases (p for trend <0.001). The number
of MSM with any other STI co-infection (excluding
syphilis), also increased in time (p for trend = 0.016,
lowest 2 in 1998, highest 13 in 2010).
In the crude analysis, MSM diagnosed in the years 2003-
2011 were more likely to live in Mid-Norway, were tested
at their own request (compared to contact tracing) when
found positive, and were more likely to have been tested be-
fore compared to those, diagnosed in 1995-2002. MSM
diagnosed in 2003-2011 were also less likely to have been
diagnosed more than 3 years since infection, to have an un-




















Figure 1 Number of MSM diagnosed with HIV infection in 1995-2011 in Norway, by year of diagnosis and time interval between this
year and the estimated year of infection (“yeargap”).
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outpatient clinic (compared to a general practitioner’s
office). After adjustment for other factors (all listed in the
Table 1), findings were similar, and in addition, MSM
diagnosed in 2003-2011 seemed to be more likely born
abroad compared to those, diagnosed in 1995-2002. The
results were significant for MSM from Asia and suggested
similar effect for MSM from other countries of Europe
(p=0.051), Africa (p=0.055) and North America (p=0.090).
A “probable” year of infection was available for 479
(48 % of total sample) cases and an “uncertain” year of
infection for a further 314 (32 %) cases (Figure 5). The
number of HIV infections increased markedly in 2003 and
remained higher afterwards. The mean time between diag-
nosis and infection for these 793 (80%) of cases was 7.1
months (interquartile range 2.7 - 23.2). In 2003, the number
of cases infected more than doubled compared to a year be-
fore (from 27 to 63) and remained at high levels afterwards.
Discussion
We have observed an increase in number of HIV diagnoses
among MSM in Norway in recent years, particularly after
2002. The majority of MSM were infected in Oslo and they
were of Norwegian origin. Although HIV is diagnosed
mainly in asymptomatic MSM, our results suggest that
most of the cases diagnosed after 2002, have been infected
less than a year before being diagnosed. We observed a
simultaneous increase of STI co-infections, which is worri-
some, as there is a potential for spread of both HIV and
other STI.
The possibility for NIPH to send a reminder to the diag-
nosing clinicians, if they fail to report a newly identified
HIV infection, contributes to a high completeness of infor-
mation [4]. There were no changes in the reporting system
in our study period and reporting delays are rare in Norway
[4]. Due to anonymous reporting, cases could be reported
twice if they are re-tested; however, laboratories do check
for duplicates in the same region before submitting a report
and further efforts to detect and remove duplicates are
done at NIPH [4]. It is worth emphasizing that all risk be-
haviour data, obtained by clinicians from their patients,
such as, for example, presumed transmission route, HIV in-
fection source partner and other risk factors for HIV trans-
mission (for example, injecting drug use), may be subject to
recall and reporting biases. Since some MSM might not be
open with their doctor about the way they were infected,
we may have missed some cases which have been classified
in other transmission groups. As the system records any in-
fection not reported previously, the HIV positive person
who immigrated to Norway is also included, if they were
tested in Norway (44 in our study population). Merging
STI into a common outcome has its limitations, as some
STIs might be recent (acute) and others, such as hepatitis
B, could be chronic with different risk factors.
The HIV surveillance data monitor the incidence of new
diagnoses rather than new infections and will be thus largely
influenced by HIV testing uptake. Since specific tests to dis-
tinguish between the early and late infection [13] are not
yet routinely applied in HIV diagnostics and reporting in
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Figure 2 Median age of MSM at the time of HIV diagnosis with interquartile range (boxes) and 10th and 90th age percentile in
1995-2011 in Norway, by year of diagnosis.
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Table 1 Selected characteristics of HIV positive MSM who were diagnosed in Norway in 1995-2011, and factors





Total sample Diagnosed in the years
2003-2011
Diagnosed in the years
1995-2002
Comparison of diagnosed in the years
2003-2011 vs. diagnosed in 1995-2002







16-24 73 (7.4) 56 (7.8) 17 (6.1) ref. group ref. group 0.418
25-34 362 (36.5) 266 (37.3) 96 (34.5) 1.0 [0.8-1.1] 1.0 [0.9-1.1]
35-44 323 (32.6) 221 (31.0) 102 (36.7) 0.9 [0.8-1.0] 1.0 [0.8-1.1]
≥ 45 233 (23.5) 170 (23.8) 63 (22.7) 0.9 [0.8-1.1] 1.1 [1.0-1.3]
Place of birth
Norway 740 (74.7) 523 (73.3) 217 (78.1) ref. group ref. group
Africa 23 (2.3) 18 (2.5) 5 (1.8) 1.1 [0.9-1.4] 1.3 [1.0-1.6]
Asia 64 (6.5) 50 (7.0) 14 (5.0) 1.1 [1.0-1.3] 1.2 [1.0-1.4]
Europe, other 92 (9.3) 71 (10.0) 21 (7.6) 1.1 [1.0-1.2] 1.1 [1.0-1.3]
North America 13 (1.3) 11 (1.5) 2 (0.7) 1.2 [0.9-1.5] 1.2 [1.0-1.6] NA
South/Mid America 59 (5.6) 40 (5.6) 19 (6.8) 0.9 [0.8-1.1] 1.0 [0.8-1.2]
Health region of residence in Norway
South-East*** 842 (85.0) 602 (84.4) 240 (86.3) ref. group ref. group NA
West 86 (8.7) 58 (8.1) 28 (10.1) 0.9 [0.8-1.1] 0.9 [0.8-1.2]
Mid-Norway 39 (4.0) 35 (4.9) 4 (1.4) 1.2 [1.1-1.4] 1.3 [1.1-1.5]
North 24 (2.4) 18 (2.5) 6 (2.2) 1.0 [0.8-1.3] 1.0 [0.8-1.3]
Year gap****
< 1 year 498 (50.2) 389 (54.6) 109 (39.2) ref. group ref. group 0.001
1-3 years 157 (15.8) 118 (16.5) 39 (14.0) 1.0 [0.9-1.1] 1.0 [0.8-1.1]
>3 years 84 (8.5) 41 (5.7) 43 (15.5) 0.6 [0.5-0.8] 0.6 [0.5-0.8]
Unknown 252 (25.4) 165 (23.1) 87 (31.3) 0.8 [0.8-0.9] 0.7 [0.6-0.9]
Reason for HIV test
Contact tracing 109 (11.0) 68 (9.5) 41 (14.8) ref. group ref. group NA
Own request 328 (33.1) 261 (36.6) 67 (24.1) 1.3 [1.1-1.5] 1.3 [1.1-1.5]
Blood donor 1 (0.1) 0 1 (0.4) excluded excluded
Immigrant 11 (1.1) 7 (1.0) 4 (1.4) 1.0 [0.6-1.6] 1.0 [0.6-1.7]
Symptoms 347 (35.0) 249 (35.0) 98 (35.3) 1.1 [1.0-1.3] 1.2 [1.0-1.4]
Unspecified 195 (20.0) 128 (18.0) 67 (24.1) 1.1 [0.9-1.3] 1.1 [0.9-1.3]
Source partner
Steady 166 (16.7) 117 (16.4) 49 (17.6) ref. group ref. group NA
Casual 590 (59.5) 442 (62.0) 148 (53.2) 1.1 [1.0-1.2] 1.1 [1.0-1.2]
Commercial sex
worker
3 (0.3) 3 (0.4) 0 excluded excluded
Other/unknown 232 (23.4) 151 (21.2) 81 (29.1) 0.9 [0.8-1.1] 1.0 [0.9-1.2]
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increase in HIV transmission and a backlog of cases, undis-
covered in the previous years.
While no systematically collected data on testing activity
among MSM in Norway in our study period exist, some
data suggest satisfactory testing rates. In a 2003 study where
MSM were approached at several gay venues in Oslo, 87%
have answered they had ever been tested for HIV (76% in
1990, 80% in 1998) [14]. In a 2007 survey in Norwegian
language that recruited respondents among visitors to a gay
Internet site [15], 69% of 2598 responding MSM reported
that they had been tested for HIV at least once and the pro-
portion who tested positive was 4% (data not published). In
a more recent internet based cross-European MSM survey
from 2010, 67% of responding MSM in Norway reported
having received the HIV test result at least once, of which
3.5% were positive [16]. A third has received the result of
their HIV test in the last 12 months in 2010 survey
[17] and 37% in 2007 survey (data not published).
We can conclude testing rates among MSM in Norway
are satisfactory, though we should be aware the test
uptake is likely lower among those who are infected
[18].
Though information on time of infection is subject to
bias, the assumption that there is an actual increase in
recently infected cases is supported by the median age
showing no significant increase over time [19]. Further-
more, results from the internet based behavioural survey
in 2010 have revealed worrisome risky behaviour, as 54%
of MSM respondents who had engaged in sex with a
non-steady partner had had anal intercourse without a
condom in the past year and more than 30% said they
did not use a condom the last time they had anal sex
with a casual partner [16].
In order to clarify the described increasing trends, our
findings call for improvements in HIV monitoring in
Norway. Regular monitoring of HIV prevalence using an-
onymous unlinked studies, as well as monitoring testing
trends and MSM behaviour in Norway are recommended.
Introduction of CD4 count in surveillance data and
approaches to reduce potential double-reporting (such as
Soundex code) should be considered, as more and more
MSM live with HIV in Norway and the risk of double
reporting after re-testing is increasing.
We aimed to estimate year of infection from the informa-
tion available, though important limitations (see above)
with this approach exist, since for 20% of diagnosed cases
the year of infection could not be estimated. Thus, our time
intervals between infection and first diagnosis are
underestimated as those excluded 20% are likely to have an
interval longer than 7 months. A French study based on
surveillance data from 2004-2007 reported much longer
time (median 25 months, interquartile range 5-55) [12].
Had we assigned an overestimate of 10 years to the
remaining 20% of cases, our median would increase to 12
months, indicating MSM in Norway are on average being
diagnosed earlier than French.
The surveillance systems of new HIV diagnoses in
European countries have varying characteristics, which
makes it difficult to compare our results, however; similar
increasing trends in diagnoses of HIV infections among
MSM of all age groups have recently been reported in
Belgium (1999-2008) [20], Germany (1999-2005) [21] and
Table 1 Selected characteristics of HIV positive MSM who were diagnosed in Norway in 1995-2011, and factors




412 (41.6) 315 (44.2) 97 (34.9) ref. group ref. group NA
Youth/STI clinic 320 (32.3) 329 (32.1) 91 (32.7) 0.9 [0.9-1.0] 0.9 [0.9-1.0]
Hospital/ outpatient
dept.
247 (24.9) 163 (22.7) 85 (30.6) 0.9 [0.8-0.9] 0.9 [0.8-1.0]
Other 12 (1.2) 7 (1.0) 5 (1.8) 0.8 [0.5-1.2] 0.8 [0.5-1.3]
Previous negative test
No previous test 336 (33.9) 221 (31.0) 115 (41.4) ref. group ref. group NA
Tested before 588 (59.3) 425 (59.6) 163 (58.6) 1.1 [1.0-1.2] 0.9 [0.9-1.0]
Unknown 67 (6.8) 67 (9.40) 0 excluded excluded
STI co-infection
None reported 858 (86.6) 617 (86.5) 241 (86.7) ref. group ref. group NA
Any 133 (13.4) 96 (13.5) 37 (13.3) 1.0 [0.9-1.1] 1.1 [0.9-1.2]
* PR – prevalence ratio.
** adjusted for all the factors, listed in the Table.
**includes Oslo.
***time between infection and diagnosis in years.
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the UK outside of London (1997-2004) [22]. Contrary to
this, data from London and the Amsterdam STI clinic
(1991-2004) suggested that an increase in HIV incidence
was observed specifically among MSM aged 35 years and
older [22,23]. Median age in our study seemed to be simi-
lar to the one in Belgium and Denmark (1990-2005) [24]
with median age 37.
Similar to our findings, in Belgium, 11% of HIV posi-
tive MSM had an STI co-infection in 2008 (data pro-
vided by participating AIDS Reference Centers) [20]. In
the period 2003-2007, as many as 31% of the 1462 newly
HIV diagnosed MSM in Spain (data from 19 HIV/STI
clinics) were diagnosed with a concurrent STI [25]. An
increase from 5% (2001) to 7% (2003) in concurrent syphilis
and HIV was reported from Germany [26]. Syphilis
outbreaks including HIV positive MSM were described in
metropolitan areas of Western Europe (London, Paris,
Dublin, Hamburg) with MSM who were mostly aware of
their HIV status [27].
HIV was the most frequently reported STI among MSM
in Norway in 2006 [8,28]. With rising HIV prevalence,
MSM are more likely to have sex with an HIV positive man
than a man with any other acute STI [29]. In addition, the



























Figure 3 Number of MSM diagnosed with HIV infection in 1995-2011 in Norway, by year of diagnosis and assumed source partner.
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transmission, is now higher, and per-contact probability of
HIV transmission has been evaluated as similar to that of
the pre-HAART era [30]. Primary HIV infection may have
a larger role in the dynamics of HIV transmission than
previously assumed, due to a higher viral load and higher
infectiousness [31]. Our results suggest similar trends in
Norway.
HIV transmission is predominantly affecting domestic-
born MSM [20,24,32], however, similar to other Western
countries, immigration has more than doubled in Norway
since 2000[33] and foreign born MSM are becoming more
represented in the recent years. Foreign born MSM are a
“difficult to reach”, heterogeneous and vulnerable popula-
tion, likely diagnosed younger than domestic-born MSM
[32]. According to guidelines issued by the Norwegian
Directorate of Health, immigrants from high HIV prevalent
areas should be offered a free confidential HIV test [34]
and support and treatment, if found positive. Nonetheless,
less than 1% of MSM were diagnosed due to immigrant
screening in our study, which is low compared to the group
of heterosexuals, infected before arrival to Norway, who
represent more than a third of all newly diagnosed HIV
cases in Norway [16]. General practitioners should be
aware that some men might be reluctant to provide
details of their sexual behaviour to their clinician,
particularly if they originate from cultures, where such
behaviour is not acceptable. Specific preventive and
testing measures, targeted at foreign born MSM, should be
evaluated.
Those diagnosed in the years 2003-2011, were more
likely to be tested at their own request compared to con-
tact tracing and less likely to be diagnosed at hospital or
outpatient clinic than by their general practitioner. With a
simultaneous decrease of AIDS and HIV illness, this might
have been the effect of a 2005 recommendation to general
practitioners for annual HIV and STI testing of MSM in
Norway [35] and other MSM targeted public health
campaigns, encouraging HIV testing. Thus, risky behaviour
among MSM, might have been accompanied by improved
awareness on importance of testing and early capture of
infections. We concur with the recommendations from
2005 and emphasize the need to target MSM with immi-
grant background, as well as to conduct thorough partner








1983-1989 1991 1993 1995 1997 1999 2001 2003 2005 2007 2009 2011
uncertain year of infection
probable year of infection
total diagnosed this year
Figure 5 Number of MSM diagnosed with HIV infection in 1995-2011 in Norway, by their estimated year of infection (bars) (N=793)
and by year of diagnosis (line) (N=991). For the incidence bars, we excluded 198 cases with unknown year of infection and grouped 31 cases
with uncertain year of infection before 1990 in one bar. Note that existing bars will increase in the coming years as new cases infected in those
years are diagnosed, especially in the most recent years. The incidence bars for the years before 1995 do not include those, diagnosed
before 1995.
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Similar increasing HIV trends are described among
MSM around Europe and a coordinated approach in
HIV monitoring, prevention and control, should be
complemented with identification of new prevention
strategies. In the light of failing preventive measures (such
as promotion of safe sex practices and condom use), pre-
exposure prophylaxis is a promising biomedical interven-
tion, however still controversial due to possible side effects
on healthy men, poor adherence among HIV negative,
costs, change in sexual behaviour and resistance issues to
name a few [36,37]. Further studies are on the way to evalu-
ate the effectiveness of this approach [37]. Effectiveness of
male circumcision on HIV transmission among MSM
remains unknown [38].
Reasons why those living in Mid-Norway are more fre-
quent among cases from 2003-2011 are not clear. Recently,
rapid testing has become available countrywide, in both
health centers and specialized clinics, as well as in outreach
centers. In the latter, this is an assumed low threshold offer
that might increase testing uptake among high risk MSM.
It remains unanswered if current healthcare services are
sufficiently targeting foreign born MSM with testing and
information on STI prevention, though this low threshold
offer could make a difference.
Conclusions
Our data suggest continuing spread of HIV among MSM
in Norway. On average, MSM are being diagnosed early
after infection, however an increasing proportion are
co-infected with an STI. This calls for prompt and effective
preventive measures as many past preventive efforts seem
to have been insufficient or failing. At the same time,
current monitoring of HIV infections among MSM has
many limitations. In the light of the increase in HIV diag-
noses among MSM, this calls for urgent improvements and
more research on HIV prevalence, regular testing activity
and risky behaviour in this population.
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